Searchable abstracts of presentations at key conferences in endocrinology

ea0028p192 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

The role of metabolic dyslipidaemia in screening for impaired glucose regulation in polycystic ovary syndrome

Aye Myint M , Kahal Hassan , Smith H , Sandeman D , Kilpatrick Eric , Atkin S

Background: Women with polycystic ovary syndrome (PCOS) are commonly associated with insulin resistance, metabolic syndrome and a family history of diabetes mellitus (DM). They are therefore at risk of diabetes and dyslipidaemia. Diabetes UK (2006) recommends screening for diabetes in PCOS patients who have a body mass index (BMI) ≥30. The recommended test is fasting plasma glucose (FPG). We therefore investigated 55 PCOS patients and 33 healthy volunteers to test the hy...

ea0028p217 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

Haemoglobin A1c in diagnosis of impaired glucose regulation in polycystic ovary syndrome

Aye Myint M , Kahal H. , Hooson F. , Sathyapalan T. , Atkin S. , Kilpatrick E.

Introduction: Impaired glucose regulation (IGR) is usually defined as impaired fasting glucose (IFG, fasting plasma glucose (FPG) is between 6.1 to 6.9 mmol/L) and/or impaired glucose tolerance (IGT, 2 hour postprandial glucose (PPG) is 7.8 to 11 mmol/L). More recently, a haemoglobin A1c (HbA1c) ≥ 42 but <47 mmol/mol has been suggested to indicate an increased diabetes risk. Women with polycystic ovary syndrome (PCOS) are strongly associated with insulin resistance a...

ea0025p7 | Bone | SFEBES2011

Vitamin D insufficiency in hyperparathyroidism

Aye Myint M , Aye Mo , Sathyapalan T , Kilpatrick E S , Atkin Stephen L

Background: Vitamin D insufficiency is very common in general population and in patients with primary hyperparathyroidism (PHPT). Measurement of serum 25OHD (25hydroxy-vitamin D) is currently the best available test to assess vitamin D adequacy. However, it has a significant seasonal variation, and is difficult to define a serum 25OHD level that is sufficient for bone health, although a serum 25OHD above 50 nmol/l has been suggested.Previous studies conf...

ea0025p146 | Diabetes, metabolism and cardiovascular | SFEBES2011

Postprandial hypertriglyceridaemia in patients with polycystic ovary syndrome

Aye Myint M , Afolabi Paul R , Sathyapalan T , Wakil Ammar , Wootton S A , Sandeman Derek D , Kilpatrick Eric S , Atkin Stephen L

Background: Postprandial hypertriglyceridaemia is an independent risk factor for cardiovascular diseases. An acute rise of insulin in the fed state suppresses hormone-sensitive lipase to inhibit free fatty acids (FFAs) mobilisation from adipose tissue, and up-regulates lipoprotein lipase to increase FFAs influx to adipose tissue from chylomicrons, that is blunted in insulin resistant states. Polycystic ovary syndrome (PCOS) is associated with insulin resistance and cardiovascu...

ea0021p151 | Diabetes and metabolism | SFEBES2009

Effect of rimonabant and metformin on oxidative stress in obese patients with polycystic ovary syndrome (PCOS)

Aye Myint M , Shepherd John , Cho Liwei , Ng J M , Marie Coady Anne , Kilpatrick Eric S , Atkin Stephen L , Sathyapalan Thozhukat

Background: Insulin resistance and obesity are characteristic features of PCOS. Oxidative stress leads to the formation of lipid peroxidation products in the skeletal muscles and has the potential to interfere with insulin signaling and thereby contribute to insulin resistance. Malondialdehyde (MDA) is a lipid peroxidation end product and is widely used as a marker of oxidative stress.Rimonabant has been shown to reduce weight and insulin resistance in o...